Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Endoscopic Sleeve Gastroplasty on Patients With Obesity and Concomitant Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Multicenter, Open-label, Randomized Controlled Trial

NCT06138821 is registered in ClinicalTrials.gov with Pichamol Jirapinyo, MD, MPH as lead sponsor.

NCT NCT06138821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06138821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Endoscopic Sleeve Gastroplasty on Patients With Obesity and Concomitant Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Multicenter, Open-label, Randomized Controlled Trial
Lead sponsor
Pichamol Jirapinyo, MD, MPH
Phase
Not applicable
Overall status
Recruiting
Start date
June 24, 2025
Completion date
June 30, 2028
Enrollment
132 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2, insulin resistance, insulin sensitivity, insulin sensitivity/resistance, liver diseases, liver fat, liver fibrosis, mash, masld, metabolic disease, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, nash with fibrosis, non alcoholic fatty liver, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, obesity, weight loss